Viscofan World You are in: The Viscofan Group EN | ES
Global

The Viscofan Group

EN | ES
Europe

Belgium

EN

Czech Republic

CS | EN

Germany

DE

Serbia

EN | SR

Spain

ES
Americas

Brazil

PT

Canada

EN | FR

Mexico

ES

United States

EN

Uruguay

ES
Asia & Oceania
Viscofan BioEngineering
Viscofan releases 1Q24 results
17/April/2024

​Main highlights of the January-March 2024 results:

• Revenue of €289.7 million, 6.0% lower than the previous year affected by the -35.0% decline in energy sales as compared with the -2.5% drop in the traditional business.

• EBITDA of €61.6 million, 0.2% below the previous year and a growth of +3.1% in like-for-like terms. Consequently, EBITDA margin has increased by 1.3 p.p. to 21.3%.

• Net profit of €31.6 million, 22.4% up on the previous year.

• Net bank debt of €176.6 million at March 2024 including a cash outflow of €36.8 million from the share buybacks carried out within the framework of the flexible remuneration program.

• José Antonio Canales, Viscofan Group CEO: “The evolution of the traditional business is in line with our expectations, that include the normalization of volumes throughout the year. In the quarter, the improvement in the Asian market stands out as compared with the ongoing weakness in South America, and the decrease in the price from the sale of co-generation electricity in Spain that is eroding revenue performance. 

Conversely, we are improving our operating profitability thanks to the production efficiencies coming from the operational improvements and the context of lower costs of raw materials and energy.

Finally, although the evolution of average exchange rates has been adverse, the improvement compared to the end of 2023 has allowed us to obtain positive exchange differences leading to double-digit growth rate in Net profit.”


You can find all results information on Viscofan´s Investor Relations website. LINK

® Viscofan Group